Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
MDGL
#801
Madrigal Pharmaceuticals, Inc. Common Stock
524.990
0
USD
-0.13%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.13%
Changement Mensuel
+17.49%
Evolution sur 6 mois
+23.93%
Changement Annuel
+23.93%
Clôture Précédente
525.670
0
Open
524.990
0
Bid
Ask
Low
524.990
0
High
524.990
0
Volume
157
Marchés
Actions des Marchés US
Soins de Santé
MDGL
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
16.02 M
17.1 M
18.14 M
19.9 M
22.08 M
22.94 M
—
Valuation ratios
Enterprise value
1.73 B
1.41 B
4.9 B
4.53 B
6.83 B
13.51 B
37.95 B
Price to earnings ratio
—
—
-16.57
-11.35
-14.09
-45.32
-123.66
Price to sales ratio
—
—
—
—
36.44
13.63
62.89
Price to cash flow ratio
—
—
-21.75
-13.08
-14.41
-68.92
-169.55
Price to book ratio
—
—
24.78
10.46
8.7
21.68
29.85
Enterprise value to EBITDA ratio
-8.38
-5.84
-16.53
-11.62
-13.51
-44.07
-115.11
Profitability ratios
Return on assets %
-0.7
-0.88
-0.81
-0.58
-0.45
-0.23
-0.25
Return on equity %
-0.84
-1.23
-1.5
-0.92
-0.62
-0.48
-0.44
Return on invested capital %
-38.24 K
-46.1 K
-60.8 K
-54.38 K
-28.26 K
-9 549.63
—
Gross margin %
—
—
—
—
96.54
100
396.71
Operating margin %
—
—
—
—
-276.39
-31.31
-138.21
EBITDA margin %
—
—
—
—
-275.78
-31.16
-140.8
Net margin %
—
—
—
—
-258.64
-30.08
-131.22
Liquidity ratios
Quick ratio
—
—
—
—
5.9
3.77
17.4
Current ratio
6.13
3.54
3.12
5.38
6.1
4.01
18.47
Inventory turnover
—
—
—
—
0.18
—
—
Asset turnover
0
0
0
0
0.21
0.83
0.83
Solvency ratios
Debt to assets ratio
—
—
0.14
0.18
0.11
0.28
0.77
Debt to equity ratio
—
—
0.25
0.29
0.16
0.58
1.47
Long term debt to total assets ratio
—
—
0.14
0.18
0.11
0.27
0.75
Long term debt to total equity ratio
—
—
0.25
0.28
0.16
0.56
1.44
Per share metrics
Operating cash flow per share
—
—
-13.12
-17.35
-21.42
-8.45
-8.54
EBIT per share
—
—
-17.13
-20.36
-23.4
-13.38
-13.65
EBITDA per share
—
—
-17.1
-20.33
-23.35
-13.31
-13.58
Total debt per share
—
—
2.91
6.27
5.62
15.5
41.76
Cash per share
—
—
20.94
33.93
43.78
43.84
167.93
Net current asset value per share
—
—
21.09
34.1
48.56
55.53
205.33
Tangible book value per share
—
—
11.52
21.69
35.24
26.54
117.13
Working capital per share
—
—
14.32
27.76
40.6
41.7
157.67
Book value per share
—
—
11.52
21.69
35.46
26.86
118.21
Nouvelles
Wolfe Research réitère sa note Peerperform sur l’action Madrigal
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
ALT Pemvidutide Explained: What Makes It Different in MASH
Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Le directeur financier de Madrigal Pharmaceuticals vend pour 854.000$
Madrigal Pharmaceuticals EVP Dier sells $854k in stock
Le PDG de Madrigal Pharmaceuticals Sibold vend pour 718.000$ d’actions
Madrigal Pharmaceuticals CEO Sibold sells $718k in shares